HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Sys. Review
Over 90% of clinicians prefer antithyroid drugs despite high relapse rates in Graves' disease
Clinicians Prefer Antithyroid Drugs for Managing Graves Disease
This targeted literature review examines the treatment landscape for Graves' hyperthyroidism, including antithyroid drugs, radioactive iodin…
While antithyroid drugs are the preferred first treatment for Graves disease, many patients still face high relapse rates and significant lo…
Frontiers
Aug 18, 2026
Allergy & Immunology
Antithyroid drug-induced agranulocytosis patients show distinct T-cell receptor repertoires compared to Graves' disease patients
Why Your Thyroid Meds Might Trigger Rare Infections
This observational study compared immune receptor repertoires in patients with antithyroid drug-induced agranulocytosis (TiA) versus those w…
A rare but deadly reaction to thyroid drugs is linked to specific immune cell changes, offering clues to predict who's at risk before infect…
medRxiv
Apr 14, 2026